Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Feb;59(2):414-20.

I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages

I-A restricted activation by T cell lines of anti-tuberculosis activity in murine macrophages

G A Rook et al. Clin Exp Immunol. 1985 Feb.

Abstract

Tuberculosis and leprosy remain two of the world's most significant diseases. Immunity involves the activation of macrophages by lymphokines but the details are unknown because there has been no objective assay for the relevant effector function using human pathogens. We previously reported the use of tritiated-uracil uptake by surviving mycobacteria as a measure of the anti-mycobacterial effect of human monocytes. We describe here the use of a modification of this assay to measure control of the proliferation of Mycobacterium tuberculosis in murine peritoneal macrophages. A bacteriostatic effect can be induced in macrophages infected with M. tuberculosis, by adding small numbers of Ly 1 +2- T cells from in vitro lines derived from immunized mice. The phenomenon is dependent on compatibility at the I-A locus of the major histocompatibility complex (MHC) and mediated by soluble factors. Such T cells also recognise and activate macrophages infected with other mycobacterial pathogens. Thus, T cells recognising shared mycobacterial antigens are active. The findings have implications for MHC linked susceptibility to mycobacterioses and the hypothesized ability of cross-reactive environmental mycobacteria to abrogate or pre-empt the protective efficacy of subsequent BCG vaccination.

PubMed Disclaimer

References

    1. J Immunogenet. 1982 Dec;9(6):445-56 - PubMed
    1. Cell Immunol. 1983 Aug;80(1):205-10 - PubMed
    1. Hum Immunol. 1982 Jul;4(4):343-50 - PubMed
    1. Infect Immun. 1981 Jan;31(1):453-64 - PubMed
    1. J Gen Microbiol. 1977 Jun;100(2):403-5 - PubMed

Substances

LinkOut - more resources